CTOs on the Move

BioMedical Enterprises, Inc.

www.bme-tx.com

 
BME designs, manufactures and markets memory metal implants used in orthopaedic reconstructive surgery and fracture management.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.bme-tx.com
  • 14785 Omicron Dr., Suite 205
    San Antonio, TX USA 78245
  • Phone: 210.677.0354

Executives

Name Title Contact Details

Similar Companies

Knoxville Orthopedic Clinic

Knoxville Orthopedic Clinic is a Knoxville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

United Claim Solutions

United Claim Solutions was started by Joshua Carder in 2004. Joshua had been in the cost containment industry for a number of years, and through that experience realized there were efficiencies and solutions that could be introduced to lower medical and administrative costs for self-insured employers, labor organizations, payers and insurers. The mission of United Claim Solutions is to be a leader and innovator of products and services for healthcare payers. We will provide superior Service, Savings and Solutions to our customers while never compromising the quality of care delivered to covered individuals.

Eggleston Youth Ctr

Eggleston Youth Ctr is a Baldwin Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bionor Pharma

Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.

Wisdo Health

Wisdo is an award-winning social health and clinical referral platform that addresses the adverse consequences of social isolation and loneliness on the mental and physical health of 124 million Americans. Research shows that Wisdo results in $1,900+ in annual medical cost savings, a 37% reduction in depression, a 34% increase in the number of healthy days experienced by our members, and an 80% retention rate on month 12. More than 1 million adults have joined the Wisdo community, where they realized measurable improvements in their health through community-driven social support, professionally moderated group sessions, and when appropriate clinical referrals based on predictive analytics.